Abstract:Despite recent advances in cancer treatment, metastasis is the cause of mortality in 90% of cancer cases. It has now been well-established that dissemination of cancer cells to distant sites occurs very early during tumorigenesis, resulting in the minimal effect of surgical or chemotherapeutic treatments after the detection of metastasis. The underlying reason for this challenge is mostly due to the limited understanding of molecular mechanisms of the metastasis cascade, particularly related to metastatic traits. Therefore, there is an urgent need to investigate this currently invisible evolution of metastasis. The tracking of metastasis evolution has not been addressed yet. Here, we introduce, for the first time, a synchronous approach to unveil the molecular mechanisms of the metastasis cascade. As cancer stem cells (CSCs) demonstrate cancer initiation, drug resistance, metastasis, and tumor relapse and can exist in a quasi-intermediate epithelial-mesenchymal transition state, the tumor-initiating events during a CSCs metamorphosis were monitored with single-cell sensitivity. Because of the invasive and resistive properties of the metastable intermediate CSCs, investigation of the molecular profiles of the quasi-intermediate CSCs was necessary for the detection of metastasis dissemination. For this purpose, the ultrasensitive technique of surface-enhanced Raman scattering (SERS) was adopted. Titanium-based, biocompatible three-dimensional (3D) nanoprobes that were synthesized for multiphoton ionization achieved a substantial SERS enhancement of ∼80-fold due to the oxygen vacancy-enriched composition of the nanoprobes. The 3D interconnected complex nanoarchitecture of the nanoprobes enabled us to entrap the nonadherent CSCs of three metastatic cancer cell lines (triple negative breast adenocarcinoma (MDAMB231), human Caucasian colon adenocarcinoma (COLO 205), and cervical adenocarcinoma (HeLa)─all very aggressive forms of cancer). The nanoprobes not only promoted the CSC proliferation to successfully attain the quasi-intermediate states but also monitored its reprogramming into a cancer cell state. The nanoprobes substantially amplified weak intracellular Raman signals to capture the molecular events during a CSC transformation. The detection of cancer was achieved with 100% accuracy. We experimentally demonstrated that the molecular signatures of CSC reprogramming are cancer-type specific. This observation enabled us to identify the origin of metastasis with 100% accuracy, providing more clarity on the relatively unknown quasi-intermediate states. This first demonstration of CSC-based tracking of metastasis evolution has the potential to provide an insightful perspective of tumorigenesis that could be useful in cancer diagnosis and prognosis as well as in the monitoring of therapeutic interventions.

A SERS-assisted 3D organotypic microﬂuidic chip for in-situ visualization and monitoring breast cancer extravasation process

Metastasis-on-a-chip Mimicking the Progression of Kidney Cancer in the Liver for Predicting Treatment Efficacy

In Situ Visualization and SERS Monitoring of the Interaction Between Tumor and Endothelial Cells Using 3D Microfluidic Networks

Two channel compartmentalized microfluidic chip for real time monitoring of the metastatic cascade

3D spheroid-microvasculature-on-a-chip for tumor-endothelium mechanobiology interplay

Perfusable Vessel-on-a-Chip for Antiangiogenic Drug Screening with Coaxial Bioprinting

Image-Assisted Microvessel-on-a-Chip Platform for Studying Cancer Cell Transendothelial Migration Dynamics

In-situ SERS Monitoring of Membrane Receptor PTK7 for Assessing Cancer Cell Migration at Single-Cell Level on a Microfluidic Chip

Ultrasensitive Optical Detection and Elimination of Residual Microtumors with a Postoperative Implantable Hydrogel Sensor for Preventing Cancer Recurrence.

Design and Construction of a Multi-Organ Microfluidic Chip Mimicking the in vivo Microenvironment of Lung Cancer Metastasis

Biological Gel-Based Microchamber Array for Tumor Cell Proliferation and Migration Studies in Well-Controlled Biochemical Gradients

Invasion/chemotaxis- and extravasation-chip models for breast cancer bone metastasis

Tumor-Vasculature-on-a-Chip for Investigating Nanoparticle Extravasation and Tumor Accumulation.

Surface protein analysis of breast cancer exosomes using visualized strategy on centrifugal disk chip

Long-term cultured microvascular networks on chip for tumor vascularization research and drug testing

3D Collagen Microchamber Arrays for Combined Chemotherapy Effect Evaluation on Cancer Cell Numbers and Migration.

Monitoring the Progression of Metastatic Breast Cancer on Nanoporous Silica Chips

Tracking the Evolution of Metastasis with Self-Functionalized 3D Nanoprobes

In Situ Probing of Cell–cell Communications with Surface-Enhanced Raman Scattering (SERS) Nanoprobes and Microfluidic Networks for Screening of Immunotherapeutic Drugs

Assessing the metastatic potential of circulating tumor cells using an organ-on-chip model

Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function